Efficacy of Haritaki Churna in Prediabetes

Efficacy of Haritaki churna in Prediabetes-A Double-Blind Randomized Controlled Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065878

Enrollment

Registered

2024-04-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R730- Abnormal glucose

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Individuals of HbA1c level between 5.7 to 6.4%

Exclusion criteria

Exclusion criteria: 1.Prediabetes with other systemic conditions like thyroid dysfunction, uncontrolled hypertension with or without medication (more than or equal to 140/90 mmHg). 2.Pregnant and lactating women. 3.Individuals on medication for longer period like glucocorticosteroids, thyroid hormones, pentamidine, nicotinic acid, antipsychotics, thiazides, ß-adrenergic agonists.

Design outcomes

Primary

Measure	Time frame
changes in Levels of HbA1c, FBS PPBSTimepoint: subjective parameters will be assessed on baseline on 0th 30th 60th 90th, day of the intervention.	—

Secondary

Measure	Time frame
Improvement in QOLTimepoint: subjective parameters will be assessed on baseline on 0th 30th 60th 90th, day of the intervention.	—

Countries

India

Contacts

Public ContactDr Suhaskumar Shetty

KAHERs Shri B M Kankanwadi Ayurveda Mahavidyalaya And Research Centre Belagavi

drsuhasshetty@gmail.com9449603234

Outcome results